Homepage | Heart
Each year the Heart editorial team selects the most meritorious research papers to receive the Heart Best Research Paper Award.. We are pleased to announce the winner and finalists for the Heart Best Research Paper Award 2024 in recognition of high quality and clinical impact.
Treating patients with ventricular ectopic beats | Heart
Ventricular ectopic beats (VEBs) are commonly seen in daily clinical practice. They are largely asymptomatic but can cause upsetting symptoms in some patients. In normal hearts, their occurrence is usually associated with no clinical significance. However, there are occasions where the presence of VEBs signifies a susceptibility towards more sinister arrhythmias, especially when heart disease ...
Treating iron deficiency in patients with heart failure: what, why ...
Introduction. Iron deficiency and anaemia, alone or in combination, are common in patients with heart failure and associated with increased risk of cardiovascular hospitalisation and death.1–3 The WHO4 defines anaemia as a haemoglobin <120 g/L for women and <130 g/L for men. Recent data suggest that even borderline anaemia (ie, 10 g/L above the WHO threshold) is associated with an increase ...
Bradyarrhythmias in patients with atrial fibrillation | Heart
The increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring or ...
Angina: contemporary diagnosis and management - Heart
### Learning objectives Ischaemic heart disease (IHD) remains the leading global cause of death and lost life years in adults, notably in younger (<55 years) women.1 Angina pectoris (derived from the Latin verb ‘angere’ to strangle) is chest discomfort of cardiac origin. It is a common clinical manifestation of IHD with an estimated prevalence of …
About - Heart
Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access options available to authors for all articles.
Atherosclerotic cardiovascular disease risk prediction: current state ...
### Learning objectives Cardiovascular disease (CVD) is the leading cause of mortality worldwide, resulting in ~18 million deaths annually.1 Atherosclerotic CVD (ASCVD) accounts for four out of every five cardiovascular (CV) deaths, one-third of which are premature.1 From 2010 to 2020, there was a global increase of ~19% in CV deaths.1 The economic burden of CVD on the European economy exceeds ...
Management of heart failure with reduced ejection fraction
### Learning objectives Heart failure is a syndrome characterised by a triad of symptoms, signs and objective evidence of cardiac dysfunction. The syndrome is divided into subtypes based on left ventricular ejection fraction (LVEF). Where the LVEF is below 40% this is termed heart failure with reduced ejection fraction (HFrEF). This differentiation …
Assessment and management of peripheral arterial disease: what …
### Learning objectives Peripheral artery disease (PAD) typically refers to atherosclerotic narrowing and/or occlusion of all arterial disease other than coronary arteries and the aorta (carotid and vertebral arteries, coeliac and mesenteric arteries, renal arteries and upper and lower limb arteries) (figure 1). As a manifestation of systemic atherosclerosis, PAD is …
Diagnosis and management of resistant hypertension - Heart
Definition of resistant hypertension. Resistant hypertension is generally defined as uncontrolled clinic blood pressure (>140/90 mm Hg) after treatment with three or more antihypertensives. 5 In the UK, National Institute for Health and Care Excellence (NICE) guidelines specify that these three should include optimal doses of an ACE inhibitor (or an angiotensin receptor blocker), a …